Periodic Reporting for period 2 - BIOSIM (Accelerating the commercialisation of a disruptive analytical technology which enables thebiopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatoryconfidence)

A new generation of biological medicines holds the promise for breakthrough treatments for cancer, cardiovascular & rare diseases for which treatment currently does not exist. The high cost of these new drugs has presented major challenges for European governments who wish to...